ANNEXURE C TO DEED OF AMENDMENT/ SCHEDULE 6 TO BID IMPLEMENTATION AGREEMENTContingent Value Rights Agreement • January 19th, 2021 • Wize Pharma, Inc. • Pharmaceutical preparations • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [●] [●], 2021 (this “Agreement”), is entered into by and among Wize Pharma, Inc., a Delaware corporation (the “Company,” or “Wize”), Wize NC, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Wize US”), OcuWize Ltd., a company incorporated under the laws of the state of Israel and a wholly owned subsidiary of Wize US (“OcuWize”), [●], as the Holders’ Representative (as defined herein), [●], as Rights Agent (the “Rights Agent”) and as initial CVR Registrar (as defined herein).
ANNEXURE B TO DEED OF AMENDMENT/ SCHEDULE 5 TO BID IMPLEMENTATION AGREEMENTStock Restriction Agreement • January 19th, 2021 • Wize Pharma, Inc. • Pharmaceutical preparations • Delaware
This STOCK RESTRICTION AGREEMENT (this “Agreement”) is made as of [Date], 2021 (the “Effective Date”), by and between Wize Pharma, Inc., a Delaware corporation (“Company”), and the stockholder named on the signature page hereto (the “Stockholder”).
EXECUTION COPYWize Pharma, Inc. • January 19th, 2021 • Pharmaceutical preparations • New South Wales
Unless the contrary intention applies, words or phrases defined in the Agreement that are not defined in this deed have the same meaning given to them in the Agreement.
